🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.190
+0.030 (2.59%)
Nov 18, 2026, 4:00 PM EST - Market closed

NanoViricides Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Selling, General & Admin
3.873.64.043.082.552.33
Research & Development
8.414.715.555.446.395.78
Operating Expenses
12.288.319.598.528.948.11
Operating Income
-12.28-8.31-9.59-8.52-8.94-8.11
Interest Expense
---0-0.05-0-0.01
Interest & Investment Income
0.10.090.120.270.360.01
EBT Excluding Unusual Items
-12.18-8.22-9.47-8.29-8.59-8.11
Pretax Income
-12.18-8.22-9.47-8.29-8.59-8.11
Net Income
-12.18-8.22-9.47-8.29-8.59-8.11
Net Income to Common
-12.18-8.22-9.47-8.29-8.59-8.11
Net Income Growth
------
Shares Outstanding (Basic)
222015121212
Shares Outstanding (Diluted)
222015121212
Shares Change
38.57%33.55%27.34%2.11%0.79%5.81%
EPS (Basic)
-0.55-0.41-0.63-0.70-0.74-0.70
EPS (Diluted)
-0.55-0.41-0.63-0.70-0.74-0.70
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-9.74-7.78-8.54-6.47-5.82-6.22
Free Cash Flow Per Share
-0.44-0.39-0.56-0.55-0.50-0.54
EBITDA
-11.76-7.78-8.85-7.76-8.2-7.39
D&A For EBITDA
0.520.530.740.760.750.72
EBIT
-12.28-8.31-9.59-8.52-8.94-8.11
SEC Filings: 10-K · 10-Q